Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Silke

Showing results (211-220 of 225) with videos related to

Pageof 23
Sort By:
Herz|December 1, 1986
A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery diseaseM A Frais, B Silke, S P Verma, et al.
Clinical Science (London, England : 1979)|October 24, 2001
Individuals with cystic fibrosis do not display impaired endothelial function or evidence of oxidative damage in endothelial cells exposed to serumL T McGrath, D McCall, C G Hanratty, et al.
Thorax|May 21, 1999
Oxidative stress during acute respiratory exacerbations in cystic fibrosisL T McGrath, P Mallon, L Dowey, et al.
Herz|February 1, 1984
Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectorisB Silke, G I Nelson, S P Verma, et al.
The American Journal of Cardiology|July 22, 1985
Intravenous amrinone in left ventricular failure complicated by acute myocardial infarctionS H Taylor, S P Verma, M Hussain, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery diseaseB Silke, D J Graham, S P Verma, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery diseaseB Silke, M A Frais, K A Midtbo, et al.
Diabetes, Obesity & Metabolism|August 23, 2002
Early vascular abnormalities and de novo nitrate tolerance in diabetes mellitusG E McVeigh, D R Morgan, P Allen, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?B Silke, S P Verma, R C Ahuja, et al.
Journal of Cardiovascular Pharmacology|April 1, 1987
Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic statusS P Verma, B Silke, S H Taylor, et al.
Pageof 23

Showing results (211-220 of 225) with videos related to

Sort By:
Pageof 23
Herz|December 1, 1986
A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery diseaseM A Frais, B Silke, S P Verma, et al.
Clinical Science (London, England : 1979)|October 24, 2001
Individuals with cystic fibrosis do not display impaired endothelial function or evidence of oxidative damage in endothelial cells exposed to serumL T McGrath, D McCall, C G Hanratty, et al.
Thorax|May 21, 1999
Oxidative stress during acute respiratory exacerbations in cystic fibrosisL T McGrath, P Mallon, L Dowey, et al.
Herz|February 1, 1984
Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectorisB Silke, G I Nelson, S P Verma, et al.
The American Journal of Cardiology|July 22, 1985
Intravenous amrinone in left ventricular failure complicated by acute myocardial infarctionS H Taylor, S P Verma, M Hussain, et al.
European Journal of Clinical Pharmacology|January 1, 1986
Pharmacokinetic, haemodynamic and radionuclide studies with nicardipine in coronary artery diseaseB Silke, D J Graham, S P Verma, et al.
Clinical Pharmacology and Therapeutics|October 1, 1987
Comparative hemodynamic dose-response effects of five slow calcium channel-blocking agents in coronary artery diseaseB Silke, M A Frais, K A Midtbo, et al.
Diabetes, Obesity & Metabolism|August 23, 2002
Early vascular abnormalities and de novo nitrate tolerance in diabetes mellitusG E McVeigh, D R Morgan, P Allen, et al.
European Journal of Clinical Pharmacology|January 1, 1984
Is the intrinsic sympathomimetic activity (ISA) of beta-blocking compounds relevant in acute myocardial infarction?B Silke, S P Verma, R C Ahuja, et al.
Journal of Cardiovascular Pharmacology|April 1, 1987
Nifedipine following acute myocardial infarction--dependence of response on baseline haemodynamic statusS P Verma, B Silke, S H Taylor, et al.
Pageof 23